Asset Details
Do you wish to reserve the book?
A thienopyridine, CB-20, exerts diuretic activity by inhibiting urea transporters
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A thienopyridine, CB-20, exerts diuretic activity by inhibiting urea transporters
Do you wish to request the book?
A thienopyridine, CB-20, exerts diuretic activity by inhibiting urea transporters
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A thienopyridine, CB-20, exerts diuretic activity by inhibiting urea transporters
2020
Overview
Urea transporters (UTs) are transmembrane proteins selectively permeable to urea and play an important role in urine concentration. UT-knockout mice exhibit the urea-selective urine-concentrating defect, without affecting electrolyte balance, suggesting that UT-B inhibitors have the potential to be developed as novel diuretics. In this study, we characterized a novel compound 5-ethyl-2-methyl-3-amino-6-methylthieno[2,3-b]pyridine-2,5-dicarboxylate (CB-20) with UT inhibitory activity as novel diuretics with excellent pharmacological properties. This compound was discovered based on high-throughput virtual screening combined with the erythrocyte osmotic lysis assay. Selectivity of UT inhibitors was assayed using transwell chambers. Diuretic activity of the compound was examined in rats and mice using metabolic cages. Pharmacokinetic parameters were detected in rats using LC–MS/MS. Molecular docking was employed to predict the potential binding modes for the CB-20 with human UT-B. This compound dose-dependently inhibited UT-facilitated urea transport with IC
50
values at low micromolar levels. It exhibited nearly equal inhibitory activity on both UT-A1 and UT-B. After subcutaneous administration of CB-20, the animals showed polyuria, without electrolyte imbalance and abnormal metabolism. CB-20 possessed a good absorption and rapid clearance in rat plasma. Administration of CB-20 for 5 days did not cause significant morphological abnormality in kidney or liver tissues of rats. Molecular docking showed that CB-20 was positioned near several residues in human UT-B, including Leu364, Val367, and so on. This study provides proof of evidence for the prominent diuretic activity of CB-20 by specifically inhibiting UTs. CB-20 or thienopyridine analogs may be developed as novel diuretics.
Publisher
Springer Singapore,Nature Publishing Group
Subject
/ Biomedical and Life Sciences
/ Cell Survival - drug effects
/ Diuretics - administration & dosage
/ Dogs
/ Dose-Response Relationship, Drug
/ Kidneys
/ Lysis
/ Membrane Transport Proteins - metabolism
/ Mice
/ Molecular Docking Simulation
/ Polyuria
/ Rats
/ Structure-Activity Relationship
/ Thienopyridines - administration & dosage
/ Thienopyridines - pharmacology
/ Urea
/ Urine
/ Vaccine
